Drug Eluting Balloon Market Growth Opportunities, Top Players, and Forecast by 2031

Drug Eluting Balloon Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Product (Coronary Drug-eluting Balloon, Peripheral Drug-eluting Balloon, Other Products); Technology (FreePac, TransPac, EnduraCoat, Other Technologies); End Users (Hospitals, Ambulatory Surgical Centers, Other End Users); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Oct 2025
  • Report Code : TIPRE00040831
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Drug Eluting Balloon Market is expected to register a CAGR of 15.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented By Product (Coronary Drug-eluting Balloon, Peripheral Drug-eluting Balloon, and Other Products (Renal/urology)), Technology (FreePac, TransPac, EnduraCoat, and Other Technologies), End Users (Hospitals, Ambulatory Surgical Centers, and Other End Users). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Drug Eluting Balloon Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Drug Eluting Balloon Market Segmentation

Product
  • Coronary Drug-eluting Balloon
  • Peripheral Drug-eluting Balloon
  • Other Products
Technology
  • FreePac
  • TransPac
  • EnduraCoat
  • Other Technologies
End Users
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Strategic Insights

Drug Eluting Balloon Market Growth Drivers
  • Increasing Prevalence of Cardiovascular Diseases: The growing incidence of cardiovascular diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), is driving the demand for drug-eluting balloons (DEBs). These balloons deliver localized drug therapy during angioplasty to prevent restenosis, making them highly effective in managing blocked arteries, improving patient outcomes, and reducing the need for repeat procedures.
  • Advancements in Balloon Technology: Technological advancements in balloon design and drug delivery systems are fueling the growth of the DEB market. Innovations such as biodegradable polymers, improved drug formulations, and enhanced coating techniques are increasing the effectiveness of DEBs, ensuring better drug absorption and fewer complications. These improvements are expanding the clinical applications of DEBs in vascular interventions.
  • Minimally Invasive Procedures Preference: The shift towards minimally invasive procedures is driving the adoption of drug-eluting balloons. These devices offer a non-surgical option for treating vascular diseases, providing faster recovery times, reduced risk of infection, and fewer complications compared to traditional surgery. This trend is encouraging healthcare professionals to use DEBs in both coronary and peripheral artery interventions.
Drug Eluting Balloon Market Future Trends
  • Focus on Hybrid Therapies: A notable trend in the DEB market is the growing interest in hybrid therapies, which combine drug-eluting balloons with stents or other treatments. This approach is aimed at enhancing treatment efficacy, preventing restenosis, and reducing complications in complex vascular conditions. Hybrid therapies are gaining traction, especially in high-risk patients, for achieving long-term vascular patency.
  • Expansion in Peripheral Artery Disease (PAD) Treatment: While DEBs have been primarily used for coronary artery disease, there is a rising trend toward their application in peripheral artery disease (PAD) treatment. The growing recognition of PAD as a major health issue, coupled with the effectiveness of DEBs in preventing restenosis in peripheral arteries, is driving the expansion of DEB usage beyond coronary applications.
  • Regulatory Approvals and Clinical Advancements: Increasing regulatory approvals and positive clinical trial results for drug-eluting balloons are accelerating market growth. As more DEB products gain approval for different vascular applications, their adoption is expected to rise. The continuous improvement in clinical outcomes, coupled with favorable regulatory pathways, is fueling the widespread use of DEBs in treating various vascular diseases.
Drug Eluting Balloon Market Opportunities
  • Emerging Markets Adoption: Emerging markets present a significant opportunity for the drug-eluting balloon market. As healthcare access improves in regions like Asia-Pacific, Latin America, and the Middle East, the demand for advanced cardiovascular treatments, including DEBs, is growing. Expanding into these markets provides opportunities for companies to introduce their products and address the rising burden of cardiovascular diseases.
  • Growth in Home Healthcare: The increasing trend toward home healthcare offers an opportunity for the drug-eluting balloon market to innovate in patient follow-up care. With advancements in telemedicine and remote patient monitoring, companies can explore ways to integrate DEBs with home care programs, allowing for improved post-procedure management and reducing healthcare system burdens.
  • Partnerships and Collaborations with Hospitals: There is an opportunity for drug-eluting balloon manufacturers to form strategic partnerships with hospitals and healthcare institutions. Collaborations can facilitate the integration of DEBs into standardized treatment protocols, allowing broader access to these devices in clinical settings. Such partnerships can drive greater adoption, improve patient outcomes, and foster innovation in DEB technology.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Drug Eluting Balloon Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Drug Eluting Balloon Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the prominent players in drug eluting balloon market?

Medtronic PLC, Boston Scientific Corporation, Becton, Dickson and Company, Terumo Corporation, Koninklijke Philips NV, Cook Group Incorporated, Biotronik, B. Braun Melsungen AG, SurModics Inc. are the some of the key market players operating in the drug eluting balloon market

Which is the fastest growing region in drug eluting balloon market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2025 - 2031)

Which region accounts for highest revenue share drug eluting balloon market?

The North America region accounts for highest revenue share drug eluting balloon market

What years does this drug eluting balloon market cover?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2023 are the historic years, 2024 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

At what CAGR the drug eluting balloon market is projected to grow?

The market is expected to grow at a CAGR of 15.2%

Major driver boosting the drug eluting balloon market growth?

Increasing prevalence of cardiovascular diseases and advancements in balloon technology are the major factors boosting the drug eluting balloon market growth


  • Medtronic PLC

  • Boston Scientific Corporation

  • Becton, Dickson and Company

  • Terumo Corporation

  • Koninklijke Philips NV

  • Cook Group Incorporated

  • Biotronik

  • B. Braun Melsungen AG

  • SurModics Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.